Exciting news! Olumiant (baricitinib) has finally been approved as a treatment for Alopecia Areata!
On June 13th, a JAK inhibitor called Olumiant became the first FDA-approved treatment for alopecia areata. Read more and find out what this means for Canadians.
CoNCERT Pharmaceuticals Reports Positive Topline Results for First CTP-543 Phase 3 Clinical Trial in Alopecia Areata
CoNCERT Pharmaceuticals' latest press release shows exciting potential for CTP-543 to be a best-in-class treatment for alopecia areata.
What Treatments are Available for Alopecia Areata?
Dermatologist Dr. Jeffrey Donovan provides an overview of the treatments available for alopecia areata in a recent blog post. Link to article is within.
What is the Alopecia Areata Scale?
Clinical experts have developed a tool called the Alopecia Areata Scale to assess the severity of alopecia areata. This tool, unlike past methods accounts for more than scalp hair loss.
COVID-19 Vaccines and Alopecia Areata: What is the Relationship?
Learn how the COVID-19 vaccine works and the relationship between mRNA vaccines and alopecia areata.
What is Patient Engagement?
You or a loved one can be involved in Alopecia Areata research. Learn more about patient engagement in research and why it's important.






